Is Promedicus a buy?

According to a note, the broker has upgraded the company’s shares to a buy rating with a trimmed price target of $55.00. Based on the current Pro Medicus share price, this implies potential upside of 21% over the next 12 months.

Is PME a good buy?

Quality Earnings: PME has high quality earnings. Growing Profit Margin: PME’s current net profit margins (47.1%) are higher than last year (41.6%).

What does Pro Medicus Limited do?

Pro Medicus Limited [ASX: PME] is a leading imaging IT provider. Founded in 1983, the company provides a full range of radiology IT software and services to hospitals, imaging centres and health care groups worldwide.

What is the share price of Afterpay?

$66.47
Afterpay Limited’s current share price is $66.47.

Who owns Pro Medicus?

Co-founder of Pro Medicus Limited in 1983, Anthony Hall has been principal architect and developer of the core software systems. His current focus is the transition to and development of the Company’s next generation RIS systems. Anthony holds a Bachelor and Master’s degree in Science from La Trobe University.

What is Visage Ris?

Visage RIS is a comprehensive, enterprise-class and state-of-the-art radiology information system (RIS).

Who owns Afterpay stock?

Square
In August 2021, Afterpay and Square, a digital payments company, announced that Afterpay would be acquired by Square. Square will pay A$39 billion in stock for the acquisition and the process is expected to be finalised in the first quarter of 2022.

What happened Afterpay stock?

Trading in Afterpay shares was suspended at the close of business on January 19, 2022, under Listing Rule 17.2. That follows lodgement of the Supreme Court of New South Wales orders with ASIC approving the Scheme of Arrangement where Block will acquire all of the issued shares in Afterpay.

What is Visage application?

Visage Ease Pro is an FDA 510(k) cleared, native iOS mobile application that provides users the ability to interpret all diagnostic imaging studies (other than mammography) on Visage 7. Learn More. Visage 7 is infinitely modular.

What is Visage PACS?

Visage Imaging is a global provider of enterprise imaging solutions that enable PACS replacement with local, regional and national scale. The Visage® 7 Enterprise Imaging Platform is proven, providing a fast, clinically rich, and highly scalable growth platform deliverable entirely from the cloud or on premise.

Is Afterpay still publicly traded?

Is Afterpay a US company?

Afterpay Limited (abbreviated as Afterpay) is an Australian financial technology company best known for its buy now, pay later service. It operates in Australia, the United Kingdom, Canada, the United States, and New Zealand. Afterpay was founded in 2014 by Nick Molnar and Anthony Eisen.